Ozempic Users Cut Grocery Spending by Up to 9%, Survey Finds

There’s now data to justify the anxiety from snack-food makers about how appetite-suppressing weight-loss shots like Ozempic will hurt their business.

When monthly grocery spending is adjusted for factors including household size and income, spending in households that use so-called GLP-1 drugs decreased by 6% to 9% versus non-GLP-1 households, Morgan Stanley said in a report, citing a survey from Numerator, a market-research provider.

Certain grocery items are particularly affected, with snacks, pastries and ice cream purchased less by households with GLP-1 users. Sales of yogurt, fish and vegetable snacks increased.

Read more: Why Weight-Loss Drugs Are Billion-Dollar Blockbusters: QuickTake ...